Ellington Financial LLC — Q2 2014 Form 10-Q
Reporting period: Quarter and six months ended June 30, 2014. The filing identifies the registrant as Ellington Financial LLC. Financial statement amounts below are in U.S. dollars; balance-sheet and income-statement amounts are shown in millions unless noted.
Business context
Ellington is an externally managed specialty finance company investing in agency and non-agency mortgage-backed securities, mortgage loans, asset-backed securities, real estate-related assets, and derivatives. Its strategy seeks risk-adjusted total returns through opportunistic asset selection, active trading, leverage, and hedging. Non-agency RMBS remained the primary driver of portfolio risk and returns.
Key financial metrics
| Metric | Q2 2014 | Q2 2013 | Six months 2014 | Six months 2013 |
|---|---|---|---|---|
| Interest income | $21.0 | $20.3 | $42.5 | $38.7 |
| Total expenses | $8.0 | $8.2 | $15.4 | $16.0 |
| Net investment income | $13.0 | $12.2 | $27.1 | $22.7 |
| Net realized and unrealized gains (losses) | $8.2 | $(0.5) | $17.0 | $29.7 |
| Increase in equity from operations | $21.2 | $11.7 | $44.0 | $52.5 |
| Increase in shareholders’ equity from operations per share | $0.81 | $0.49 | $1.69 | $2.35 |
The filing does not present a conventional sales-revenue line; interest income is its principal investment-income measure. Net interest margin, including interest-rate swap payments but excluding other hedging costs, was 4.34% for Q2 and 4.32% for the first half. Shareholder net-asset-value total return, assuming reinvested distributions, was 3.36% for Q2 and 7.03% for the first half.
- June 30 balance sheet: Assets $2,921.2; liabilities $2,290.1; total equity $631.1; common shareholders’ equity $624.1. Book value was $24.53 per common share; diluted book value was $24.14.
- Cash and cash flow: Cash and equivalents were $145.0, down from $183.5 at year-end 2013. Net cash provided by operating activities was $48.4 for the first half, while financing activities used $86.9; cash declined by $38.5. Operating cash flow reflects substantial investment purchases, sales, and settlement activity.
- Debt and liquidity: Reverse-repurchase borrowings were $1,188.8 and securitized debt was $0.9. Management reported debt-to-equity of 1.89:1, versus 1.98:1 at December 31, 2013. Reverse repos had a 0.74% weighted-average rate and 62-day average remaining maturity; 31% matured within 30 days. The stated overall weighted-average contractual haircut was 13.9%.
- Portfolio and leverage: Long investments at fair value totaled $1,753.8; investments sold short totaled $852.8. Long investments included $1,096.1 of agency securities and $513.9 of private-label securities. Non-agency investments and other ABS were $638.0 in the MD&A portfolio summary. Level 3 investments totaled $693.9, reflecting material reliance on unobservable valuation inputs.
- Distributions: The company paid $1.54 per share for the first half, compared with $2.29 in the prior-year period. On August 5, the board approved a further $0.77 per share dividend, payable September 15, 2014.
Material changes versus comparable periods
- Q2 shareholders’ operating results rose to $20.9 from $11.6, primarily because investment gains improved markedly from the prior-year loss; derivative results moved to a $6.6 loss from a $16.9 gain.
- For the first half, shareholders’ operating results fell to $43.6 from $51.9, despite higher net investment income. Derivative results shifted to a $7.8 loss from a $10.3 gain; investment gains also declined from $19.5 to $24.1, partly offsetting that effect.
- Non-agency portfolio value increased 3.1% during Q2 to $657.7, while agency RMBS value increased to $961.8. The company increased CLO, European non-dollar RMBS, and residential non-performing/sub-performing loan holdings; CLO holdings rose to $81.3 from $47.5 at March 31.
- Average repo financing costs declined year over year in Q2: agency to 0.36% from 0.41%, and non-agency to 1.92% from 2.04%. Total average borrowing cost was 0.77% versus 0.89%.
Outlook, risks, and unusual items
- No numerical earnings or return guidance was provided. Management said repo financing remained readily available and competition among lenders had increased, but warned that future bank regulation could affect financing availability, terms, and market liquidity.
- Management described a favorable Q2 market backdrop: mortgage and non-agency assets rallied as long-term rates declined, credit spreads tightened, and foreclosure inventory fell. It also cautioned that non-agency markets could be vulnerable to rising rates and retail fund outflows, and that agency valuations could face pressure from Fed tapering, mortgage production, and increased prepayments.
- Key exposures include interest-rate, credit, prepayment, financing, collateral-margin, counterparty, and valuation risks. The company relied heavily on short-term reverse repos, with $1.2 billion outstanding and 39% of open repos concentrated with two counterparties. It reported $206.1 million of aggregate repo counterparty amount at risk and $21.0 million of derivative amount at risk.
- Management’s rate-sensitivity model estimated portfolio-value declines of $2.3 million for an immediate 50-basis-point rate increase and $7.8 million for a 100-basis-point increase, assuming a static portfolio. The filing cautions that actual outcomes may differ materially.
- Fair values for significant Level 3 holdings depend on third-party quotes and models using assumptions about yields, prepayments, losses, recoveries, and resolution timelines. Management stated that valuation uncertainty could materially affect reported fair values.
- The company held $17.1 million of non-performing commercial mortgage loans. No material legal proceedings were reported, but management noted ongoing regulatory inquiries involving Ellington and affiliates may lead to further investigation or proceedings. Management reported effective disclosure controls and no material change in internal control over financial reporting.
Important facts for investors to verify
- Whether the $0.77 quarterly dividend is supported by recurring investment income and sustainable cash generation, given leverage and the decline in cash.
- The composition, financing haircuts, maturity schedule, and counterparty concentration of reverse repos, and the company’s capacity to meet margin calls or refinance maturing borrowings.
- The sensitivity of Level 3 asset valuations and reported book value to changed collateral, prepayment, loss, and resolution assumptions.
- How much Q2 and first-half returns depended on realized and unrealized market gains, and how hedges performed as rates and credit spreads moved.
- Whether non-agency spread tightening, rising asset prices, and changing Federal Reserve policy alter expected returns, prepayment exposure, and liquidity.